Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: BJU Int. 2018 Nov 2;123(5):854–860. doi: 10.1111/bju.14580

Table 3.

Mode of diagnosis by prostate cancer characteristics and trial arm.

Intervention Usual Care
% Symptomatic
(total N) 1 		% Symptomatic
(total N) 1 		p-value (I vs. C)
Gleason 8–10 21.6 (561) 27.5 (619) 0.02
Gleason 2–7 14.6 (4404) 21.0 (3949) <0.0001
p-value (Gleason 8–10
vs 2–7)		 <0.0001 0.0003
       
Metastatic Disease 37.8 (111) 49.6 (133) 0.06
No metastatic disease 15.0 (4971) 21.4 (4537) <0.0001
p-value (Metastatic vs.
non metastatic)		 <0.0001 <0.0001
1.

Total with known mode of diagnosis